Sage Journals: Discover world-class research

Abstract

Background

Current guidelines suggest treatment for many individuals who may never develop a stroke. We hypothesized that a combination of coronary artery calcification (CAC) and carotid artery intima-media thickness (CIMT) data could better individualize risk assessment for ischemic stroke and transient ischemic attack events.

Methods

A total of 4720 individuals from the Multi-Ethnic Study of Atherosclerosis were evaluated for ischemic stroke and transient ischemic attack. Cox proportional hazards models for time to incident ischemic stroke/transient ischemic attack were used to examine CAC and CIMT as ischemic stroke/transient ischemic attack predictors in addition to traditional risk factors. We calculated the 10-year number needed to treat by applying the benefit observed in ASCOT-LLA to the observed event rates within CAC and CIMT strata.

Results

Median follow-up was 13.1 years. Compared with individuals with no CAC and with CIMT ≤ 75th percentile, stroke/transient ischemic attack risk increased progressively with each CAC category (0, 1–100, >100) among individuals with CIMT > 75th percentile. Among participants eligible for statin therapy based on the 2013 atherosclerotic cardiovascular disease (ASCVD) guidelines (ASCVD risk of >5%), 739/2906 (25%) had no CAC and CIMT ≤ 75th percentile and an observed ischemic stroke/transient ischemic attack rate of 2.49 per 1000 person-years. The predicted 10-year number needed to treat was 292 for no CAC and CIMT ≤ 75th percentile and 57 for CAC > 100 and CIMT > 75th percentile.

Conclusion

The combination of CIMT and CAC could serve to further refine risk calculation for ischemic stroke/transient ischemic attack prevention and may prioritize those in most need of statin therapy to reduce ischemic stroke/transient ischemic attack risk.

Keywords

Carotid artery intima-media thickness ischemic stroke/transient ischemic attack coronary artery calcification

Get full access to this article

View all access options for this article.

References

Stone

Robinson

Lichtenstein

et al.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2889–2934.

Goff

Jr Lloyd-Jones

Bennett

et al.

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2935–2959.

DeFilippis

Young

Carrubba

et al.

An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med 2015; 162: 266–275.

Meschia

Bushnell

Boden-Albala

et al.

Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 3754–3832.

Nasir

Bittencourt

Blaha

et al.

Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2015; 66: 1657–1668.

Hermann

Gronewold

Lehmann

et al.

Coronary artery calcification is an independent stroke predictor in the general population. Stroke 2013; 44: 1008–1013.

Osawa

Nakanishi

Budoff

. Is there a role for coronary artery calcification scoring in primary prevention of cerebrovascular disease? Atherosclerosis 2017; 257: 279–287.

O’Leary

Polak

Kronmal

et al.

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14–22.

Bild

Bluemke

Burke

et al.

Multi-Ethnic Study of Atherosclerosis: Objectives and design. Am J Epidemiol 2002; 156: 871–881.

10.

Carr

Nelson

Wong

et al.

Calcified coronary artery plaque measurement with cardiac CT in population-based studies: Standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005; 234: 35–43.

11.

Polak

Szklo

Kronmal

et al.

The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2013; 2: e000087–e000087.

12.

Sever

Dahlof

Poulter

et al.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial – Lipid Lowering Arm (ASCOT-LLA): Multicentre randomised controlled trial. Lancet 2003; 361: 1149–1158.

13.

Budoff

Young

Burke

et al.

Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: The Multi-Ethnic Study of Atherosclerosis (MESA). Eur Heart J 2018; 39: 2401–2408.

14.

Gronhoj

Gerke

Mickley

et al.

External validity of a cardiovascular screening including a coronary artery calcium examination in middle-aged individuals from the general population. Eur J Prev Cardiol 2018; 25: 1156–1166.

15.

Gepner

Young

Delaney

et al.

Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2015; 8: e002262–e002262.

16.

Gepner

Young

Delaney

et al.

Comparison of carotid plaque score and coronary artery calcium score for predicting cardiovascular disease events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2017; 6.

17.

Polak

Pencina

O’Leary

et al.

Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke 2011; 42: 3017–3021.

18.

Blaha

Cainzos-Achirica

Greenland

et al.

Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2016; 133: 849–858.

19.

Valenti

Ó Hartaigh

Heo

et al.

A 15-year warranty period for asymptomatic individuals without coronary artery calcium: A prospective follow-up of 9,715 individuals. JACC Cardiovasc Imaging 2015; 8: 900–909.

20.

Seshadri

Beiser

Kelly-Hayes

et al.

The lifetime risk of stroke: Estimates from the Framingham Study. Stroke 2006; 37: 345–350.

21.

Iino

Yokoyama

Konno

et al.

Impact of combined assessment of coronary artery calcium score, carotid artery plaque score, and brachial-ankle pulse wave velocity for early coronary revascularization in patients with suspected coronary artery disease. Int Heart J 2012; 53: 154–159.

22.

Budoff

Nasir

McClelland

et al.

Coronary calcium predicts events better with absolute calcium scores than age–sex–race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009; 53: 345–352.

23.

Baber

Mehran

Sartori

et al.

Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: The BioImage study. J Am Coll Cardiol 2015; 65: 1065–1074.

24.

Budoff

McClelland

Nasir

et al.

Cardiovascular events with absent or minimal coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2009; 158: 554–561.

25.

Gibson

Blaha

Arnan

et al.

Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. JACC Cardiovasc Imaging 2014; 7: 1108–1115.

26.

Piepoli

Hoes

Agewall

et al.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315–2381.

27.

Gysan

Millentrup

Albus

et al.

Substantial improvement of primary cardiovascular prevention by a systematic score-based multimodal approach: A randomized trial: The PreFord-Study. Eur J Prev Cardiol 2017; 24: 1544–1554.

28.

Graversen

Abildstrom

Jespersen

et al.

Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study. Eur J Prev Cardiol 2016; 23: 1546–1556.

29.

Mortensen

Nordestgaard

Afzal

et al.

ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: The Copenhagen General Population Study. Eur Heart J 2017; 38: 586–594.

30.

Mahabadi

Mohlenkamp

Lehmann

et al.

CAC score improves coronary and CV risk assessment above statin indication by ESC and AHA/ACC primary prevention guidelines. JACC Cardiovasc Imaging 2017; 10: 143–153.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.11 MB

Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins

Abstract

Background

Methods

Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material